The Food and Drug Administration (FDA) is strongly considering passing approval for a COVID-19 vaccine booster for ages as young as 40 and older. This could greatly increase the number of people who may be eligible for the shot. If approved, changes would not take place until next month, following their address of other items pending approval.


The nation is waiting to hear the FDA’s answer on whether or not a Moderna vaccine booster will be approved for people ages 65 and older, as well as those who are at an elevated risk for COVID-19. They are also pending approval on an extra shot for the Johnson & Johnson vaccine in those over the age of 18.


A booster shot for the Pfizer-BioNTech vaccine has already been cleared for senior adults (ages 65 and older) and for those at high risk for COVID-19 due to medical conditions or job exposure (including healthcare and senior living). The Pfizer-BioNTech vaccine is also pending approval for those ages 5 to 11 years old, which is expected to clear as early as next month.


Professor of public health and epidemiology at the University of Michigan, Arnold S. Monto says of the possible booster, “The concern that I have is that we don’t want to wait until we see some more severe infections in the under 65-year-old general population, because getting this vaccine out takes time and requires extreme logistic efforts.”


If you have any questions regarding the COVID-19 vaccine or your personal eligibility for a booster shot should there be approval, contact your primary care services provider at NeighborMD, MSO services.